Rethinking Pharmaceutical Innovation Policy

Misaligned incentives account for many of the most troubling features of the pharmaceutical industry’s present practices and performance.
const trinityScript = document.createElement('script'); trinityScript.setAttribute('fetchpriority', 'high'); trinityScript.src = 'https://trinitymedia.ai/player/trinity/2900011009/?pageURL=' + encodeURIComponent(window.location.href); document.currentScript.parentNode.insertBefore(trinityScript, document.currentScript);

Liquidity dependencies in the euro area

This study investigates to what extent the significant liquidity injections by the ECB over the past 15 years may have created a dependency by banks on central bank liquidity itself. Following Acharya et al. (2024), I examine whether the ECB's liquidity provision changed banks' incentives to increase liquid deposits, potentially heightening their susceptibility to liquidity shocks.

From purchases to exit: central bank interventions in corporate debt markets

Central banks increasingly act as market-makers-of-last-resort, yet the impact and exit of such interventions remain poorly understood. Using euro-area data, we analyze the cycle of market freeze, intervention, and exit in short-term debt markets. A run on money market funds (MMFs) triggered a collapse in these markets in March 2020. Firms replaced only 27% of lost funding through credit lines. The European Central Bank intervened, fully replacing MMFs for some firms and allowing them to issue more debt at lower rates and longer maturities.

Pages

Subscribe to Front page feed